Literature DB >> 34367808

Comparison of Positivity Rates of Rapid Antigen Testing and Real-Time Polymerase Chain Reaction for COVID-19 During the First and Second Waves of the Pandemic in Eastern Uttar Pradesh, India.

Vivek Hada1, Rama S Rath2, Aroop Mohanty1, Rishabh Sahai3, Kanishka Kumar4, Subodh Kumar5, Hari S Joshi6, Surekha Kishore2.   

Abstract

Background The advent of the second wave of coronavirus disease 2019 (COVID-19) in India caused a new range of challenges in diagnosing the virus. Various point-of-care tests have been introduced for rapid diagnosis. Although rapid antigen tests are the most commonly used, the false-negative rates are high. Therefore, the purpose of this study was to compare the positivity rate of real-time polymerase chain reaction (RT-PCR) testing in rapid antigen-negative cases of COVID-19 during the first and second waves of the COVID-19 pandemic. Methodology This was an observational study conducted in the Department of Microbiology, All India Institute of Medical Sciences, Gorakhpur. Results In total, 2,168 patients were tested. The percentage positivity rate of the RT-PCR tests among the antigen-negative samples was 4.34% in the first wave of the pandemic whereas it was 8.08% in the second wave. Conclusions The main conclusion of this study was that antigen tests should never be used alone for the diagnosis of COVID-19. Instead, they should be confirmed with a RT-PCR test.
Copyright © 2021, Hada et al.

Entities:  

Keywords:  covid-19; positivity rate; rat; real-time polymerase chain reaction (rt-pcr); second wave

Year:  2021        PMID: 34367808      PMCID: PMC8341255          DOI: 10.7759/cureus.16206

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  1 in total

1.  Can Self-Administered Rapid Antigen Tests (RATs) Help Rural India? An Evaluation of the CoviSelf Kit as a Response to the 2019-2022 COVID-19 Pandemic.

Authors:  Marika Vicziany; Jaideep Hardikar
Journal:  Diagnostics (Basel)       Date:  2022-03-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.